Heron begins Phase II trial of HTX-011 to treat post-operative pain
The initiation of the placebo-controlled, dose-finding trial follows clearance from the US Food and Drug Administration (FDA) of the company’s investigational new drug (IND) application for HTX-011. HTX-011,